Chapter 34: Immunity to Infections, CD Molecules, and Cytokines
IMMUNITY TO INFECTION
Human beings are exposed to various microorganisms like:
- Bacterial
- Viral
- Fungal
Besides, some of these are pathogenic organisms. After entering into the body, they cause infection, and our immune system becomes active to get rid of these pathogenic microorganisms.
Non-Specific or Non-Immunological Host Defence Mechanism
These are as follows:
- Surface defense.
- Specific or Acquired Immunity.
- Physiological Means.
- Others.
- Immunization.
Physical
The following are the barrier to entry of the pathogenic microorganism:
- Intact mucous membranes and intact skin will prevent the entry of Micro-organism.
- Coughing and sneezing will expel out microorganisms.
- Epithelial cell turnover also prevents the settling of the microorganism.
Chemical
Various chemicals give us immunity like:
- Gastric acid (low pH) is a local disinfectant and retards salmonella and cholera vibrio growth.
- Skin lipids produce an acidic medium (low pH) so as not suitable for bacteria growth.
- Vaginal secretion inhibits bacterial growth.
- Lysozyme and interferon present in tears, saliva, and nasal secretion attack bacterial cell wall, and lysozyme are bactericidal.
- Spermin prostatic secretion inhibits the growth of gram-positive bacteria.
Humoral
These are various humoral factors present in the serum-like:
- The alternative complement pathway is bactericidal.
- Acute-phase proteins like CRP increase 1000 times in response to pyogenic infection. It binds to bacteria. Other acute phase proteins are α1-antitrypsin, β2-macroglobulin, fibrinogen, ceruloplasmin, and factor B.
Body Surface Bacteria
These body-surface bacteria, which are normally present, may produce the natural antibody or compete with pathogenic bacteria for nutrition.
They also produce antibacterial substances like anaerobic bacteria in the intestine produce a fatty acid, which will retard bacterial growth. Another example is colicin and acid.
SPECIFIC OR ACQUIRED IMMUNITY
This will take place through
- B-lymphocytes = Ab-mediated.
- T-lymphocytes = Cell-mediated.
Ab-Mediated (B-L) Methods
- Opsonization by IgG or IgM.
- Neutralization of toxin by IgG.
- Lysis of bacteria by IgG & IgM.
- ADCC (Antibody-Dependent Cellular Cytotoxicity).
T-Cell Mediated Methods
- By CD8+ cells—Cytotoxic injury.
- By CD4+ cells—this may act as effectors cells give cell-mediated immunity.
- Lymphocytes may produce lymphokines.
Complement Mediated Immunity
The complement may be activated by bacteria or other pathogens and leads to the lysis of targets.
- Body temperature: Some bacteria have poor growth at 37Co.
- Oxygen-Tension: This is high in the lung, and it will inhibit the growth of anaerobes.
- Hormonal imbalance, like the raised levels of corticosteroids, has an anti-inflammatory effect.
- Age: Young and old aged are more prone to infection.
- Species: Some of the species are resistant to certain diseases like leprosy is not seen in animals.
- Racial: Sickle cell patients are immune to malarial infection. This racial immunity is absolute in plants.
- Individuals: Tuberculosis in twins has 85% chances if they are monovular while 25% are binovular.
This is an artificial process where an individual is rendered immune.
Active Immunization
It makes a non-immune individual acquires a long-lasting ability to respond to an organism or its toxic products by generating its own protective mechanisms.
Active immunization may be:-
- Natural acquired by infection or low virulent organisms.
- Artificial through vaccination.
Passive Immunization
This is the process of acquiring protective immunity without the need for an immune response on the part of the individual.
Passive immunity may be:
- Natural transfer of Ab (IgG) from mother to infant takes place through placental circulation or colostrum, a rich source of IgA.
- Artificial passive antibody therapy (serum therapy), e.g., administration of immunoglobulin.
MAJOR CYTOKINES
Name | Old Name | Cell Releasing | Cells Target | Effect |
Interferon α IFN-α |
MPS | ALL |
Antiviral ↑ MHC Expression |
|
Interferon β | MAC / MIF | Fibroblast | All |
Antiviral ↑ MHC Expression |
Interferon γ | T-L |
Macrophages B-L T-L NK |
Activate Ig class-selection activate and influence TH | |
TNF-α Tumor Necrosis Factor-α |
Macrophages |
Macrophages Neutrophil All cells T-L |
Activation ↑Cytotoxicity ↑ MHC Expression cytotoxic Co-signal for activation cytotoxic |
|
Interleukin 1 | MPS |
Endothelium
T-L |
Procoagulant ↑adhesion molecule Co-signal T-cell activation |
|
Interleukin 2 | T-cell growth factor |
T-L Mainly TH1 |
T-L
B-L |
The major autocrine & paracrine. T-cell growth factor: activate Tc. Growth and differentiation factor |
Interleukin 3 |
Multilineage Colony sti-factor |
T-cells Th1 & Th2 |
Immature B.M progenitor cells | Promote growth & differentiation |
Interleukin 4 | T-L (Th2) |
T-L B-L |
Growth factor for Th2 and inhibitory for Th1 Activator and growth factor |
|
Interleukin 5 | T-L (Th2) | Eosinophils | Growth & differentiation promote the killing of helminths. | |
Interleukin 6 |
T-L (Th2) MPS |
B-L Liver |
Growth factor Acute-phase proteins |
|
Interleukin 7 | Marrow stromal cells |
Developing B-cells |
Growth and differentiation | |
Interleukin 8 |
MPS, T-cell, Endothelium |
Neutrophil | Activation | |
Interleukin 10 |
T-cells (Th2) |
T-L
B-L |
The immunosuppressant effect inhibits cytokines release & proliferation of T-cells. With IL-4 influences, differentiation of Th1 to Th2 Promotes differentiation |
|
Interleukin 12 |
T-cells B-cells NK Monocytes CD4+ |
NK
CD4+ |
Most potent stimulator Enhance IFN-γ release by NK and cytotoxic activity
Inhibits proliferation |
|
Transforming growth factor β |
T-cells MPS |
TC | Inhibits maturation | |
Granulocyte CSF (G-CSF) |
CD4+ T-cells MPS Endothelium |
Granulocytes | Promote growth and differentiation | |
Granulocyte Macrophage CSF GM-CSF |
CD4+ T-cells MPS Endothelium |
Granulocytes & monocytes |
Promote growth and differentiation Activate mature forms |
|
Monocytes Macrophages CSF |
MPS cells | Monocytes & Macrophages | Promote growth and differentiation |
Interferons
Interferon-β IFN-β |
Fibroblasts | Same activities as IFN-α |
Interferon-α IFN-α |
Leucocytes |
It inhibits viral replication and tumor growth: increase class-I and class-II MHC expression. ↑ NK activity and modulate Ab response. |
Tumor Necrosis Factor-β TNF-β (Lymphotoxin) |
T-cells | Cytotoxic factor |
Transforming growth factor (TGF) TGF-α |
Solid tumors, carcinoma monocytes | Induce angiogenesis, keratinocytes proliferation, tumor growth & bone resorption |
TGF-β | Platelets, placenta, Kidney, T & B-cells | Induce fibroblastic proliferation, collagen & fibronectin synthesis inhibit Tc, NK, inhibit B & T-cells proliferation. Enhance wound healing and angiogenesis |
Important CD Molecules
CD Designation | Main Cellular Expression | Functions |
CD | A cluster of differentiation. These are glycoproteins present on the surface of various cells. | |
CD2 | T-L & NK cells | Adhesion molecule, T-L activation |
CD3 | T-L | Signal transduction as a result of Ag-recognition by T-L |
CD4 | MHC-II restricted T-cells | Adhesion molecule (binds to MHC-II) signal transduction |
D5 | T-cells & B-cell subset | Unknown |
CD8 | MHC-I restricted T-cells | Adhesion molecule (binds to class-I MHC) signal transduction |
CD15 | Granulocytes | It is a ligand for selectin. |
CD16 |
NK cells Granulocytes Macrophages |
Low-affinity Fcγ-R, ADCC activation of NK cells |
D19 | B-cells | Role in B-cell activation |
D20 | B-cells | Role in B-cell activation |
D21 | Mature B-cell | Receptor for C3 & EBV. Role in B-cell activation |
D22 | B-cells | Role in cell adhesion & B-cell activation |
D23 |
Activated B-cells Macrophages |
Low-affinity Fcε-R induced by Il-4. |
D28 | T-cells (Most CD4+) & some CD8+ | T-cells receptor for co-stimulation molecules B7-B7-2 |
D56 | NK cells | Adhesion molecule |
D81 | Broad | Associated with CD19 & CD21, role in B-cell activation |